HIGH-DOSE BUSULFAN AND MELPHALAN AS CONDITIONING REGIMEN PRIOR TO TRANSPLANTATION

被引：0
|
作者：
MARIT, G
CONY, P
DAVID, B
BROUSTET, A
REIFFERS, J
机构：
来源：
BONE MARROW TRANSPLANTATION | 1988年 / 3卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：78 / 78
页数：1
相关论文
共 50 条
  • [41] UNRELATED ALLOGENEIC BONE-MARROW TRANSPLANTATION USING HIGH-DOSE BUSULFAN AND CYCLOPHOSPHAMIDE (BU-CY) CONDITIONING REGIMEN
    SAHEBI, F
    BOLWELL, B
    CRILLEY, P
    FRANE, M
    TERRITO, M
    GAJEWSKI, J
    COPELAN, E
    BLOOD, 1993, 82 (10) : A81 - A81
  • [42] TOXICITY OF HIGH-DOSE BUSULFAN AND CYCLOPHOSPHAMIDE AS A PREPARATIVE REGIMEN FOR BONE-MARROW TRANSPLANTATION
    KASAI, M
    KIYAMA, Y
    WATANABE, M
    SETO, K
    MATSUURA, A
    TANAKA, J
    TAKEDA, H
    NAOHARA, T
    HIGA, T
    HASHINO, S
    KOBAYASHI, H
    KOBAYASHI, M
    IMAMURA, M
    SAKURADA, K
    MIYAZAKI, T
    TRANSPLANTATION PROCEEDINGS, 1992, 24 (04) : 1529 - 1530
  • [43] Busulfan plus cyclophosphamide and etoposide versus high-dose melphalan as conditioning in autologous stem cell transplantation for newly diagnosed multiple myeloma
    Lim, Sungnam
    Park, Seon Yang
    Lee, Yongjun
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S153 - S153
  • [44] High-dose idarubicin (I) and melphalan (M) with total body irradiation (TBI) or busulfan (Bu) as conditioning for allogeneic and autologous transplantation (SCT).
    Juliusson, G
    Malm, C
    Karlsson, K
    BONE MARROW TRANSPLANTATION, 1999, 23 : S74 - S74
  • [45] HIGH-DOSE BUSULFAN AND MELPHALAN BEFORE BONE-MARROW TRANSPLANTATION FOR ACUTE NONLYMPHOBLASTIC LEUKEMIA
    MARTINO, R
    BADELL, I
    BRUNET, S
    SUREDA, A
    TORRAS, A
    CUBELLS, J
    DOMINGOALBOS, A
    BONE MARROW TRANSPLANTATION, 1995, 16 (02) : 209 - 212
  • [46] High-dose treosulfan in conditioning prior to hematopoietic stem cell transplantation
    Glowka, Franciszek K.
    Romanski, Michal
    Wachowiak, Jacek
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2010, 19 (10) : 1275 - 1295
  • [47] Busulfan, melphalan, and bortezomib compared to melphalan as a high dose regimen for autologous hematopoietic stem cell transplantation in multiple myeloma: long term follow up of a novel high dose regimen
    Hagen, Patrick
    D'Souza, Anita
    Hari, Parameswaran
    Davila, Omar
    Zhang, Mei-Jie
    Vesole, David H.
    Smith, Scott E.
    Rodriguez, Tulio E.
    Stiff, Patrick J.
    LEUKEMIA & LYMPHOMA, 2020, 61 (14) : 3484 - 3492
  • [48] A PHASE I STUDY OF CLOFARABINE PLUS HIGH DOSE MELPHALAN AS A CONDITIONING REGIMEN FOR ALLOGENEIC TRANSPLANTATION
    Kirschbaum, M.
    Stein, A. S.
    Nakamura, R.
    Nademanee, A.
    Popplewell, L.
    Delioukina, M.
    Chen, R.
    Snyder, D.
    Conrad, J.
    Frankel, P.
    Forman, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 64 - 65
  • [49] Single daily dose of intravenous busulfan and melphalan as conditioning regimen for patients with multiple myeloma undergoing autologous stem cell transplantation
    de la Rubia, J.
    Lahuerta, J.
    Gonzalez, J.
    Solano, C.
    Rivas, P.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S323 - S323
  • [50] A PHASE I STUDY OF CLOFARABINE PLUS HIGH DOSE MELPHALAN AS A CONDITIONING REGIMEN FOR ALLOGENEIC TRANSPLANTATION
    Kirschbaum, M. H.
    Stein, A. S.
    Nakamura, R.
    Auayporn, N.
    Popplewell, L.
    Delioukina, M.
    Chen, R.
    Snyder, D.
    Conrad, J.
    Frankel, P.
    Forman, S. J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S278 - S278
12345